Hyponatremia of non-small cell lung cancer: Indian experience

BACKGROUND: Hyponatremia is a hazardous complication of lung cancer and its treatment. It is seen at presentation in approximately 15% of patients with small-cell lung cancer (SCLC) and 1% of patients with non-small cell lung cancer (NSCLC). Platinum compounds used as first-line agents along with ta...

Descripción completa

Detalles Bibliográficos
Autores principales: Bose, Chinmoy K., Dey, Subhashis, Mukhopadhyay, Ashis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342719/
https://www.ncbi.nlm.nih.gov/pubmed/22557779
http://dx.doi.org/10.4103/0971-5851.92810

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342719/
https://www.ncbi.nlm.nih.gov/pubmed/22557779
http://dx.doi.org/10.4103/0971-5851.92810

Ejemplares similares